Sasisopin Kiertiburanakul
270 Rama VI Road
Bangkok, 10400, Thailand
Bangkok, 10400, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 163 publications
Trends in frequency of HIV viral load and CD4 cell count monitoring among Asian cohort of adults with HIV: an analysis of the TREAT Asia HIV Observational Database, 2003-2018.
Journal: medRxiv : the preprint server for health sciences
Published: April 03, 2026
Impact of COVID-19 pandemic on treatment outcomes among people living with HIV in Thailand: A nested case-control study.
Journal: Journal of infection and public health
Published: March 17, 2026
Changes in Metabolic Parameters After Switching From Efavirenz to Dolutegravir-Based Regimen: A Cohort Study in Thai People Living With HIV.
Journal: Journal of the International Association of Providers of AIDS Care
Published: March 10, 2026
B/F/TAF in people with both HIV-1 and hepatitis B: outcomes from the ALLIANCE open-label extension phase.
Journal: AIDS research and therapy
Published: February 11, 2026
Kidney dysfunction in adults living with HIV and HBV: a 10-year retrospective cohort study across seven Asia-Pacific countries.
Journal: AIDS research and therapy
Published: September 01, 2025
Respiratory Syncytial Virus Infection in Older Adults in Asia: A Modified Delphi Expert Consensus on Surveillance, Diagnosis, and Prevention.
Journal: Pulmonary therapy
Published: August 12, 2025
Lingering sex and age disparities in dolutegravir uptake among adults with HIV: A multi-country observational cohort study.
Journal: medRxiv : the preprint server for health sciences
Published: July 15, 2025
Low Cholesterol Associated With TB in People Living With HIV in an Asia-Pacific Cohort.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: April 29, 2025
Effect of dolutegravir on weight changes and lipid profile compared with efavirenz in people living with HIV: A retrospective cohort study.
Journal: Journal of infection and public health
Published: October 20, 2024
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial.
Journal: The Lancet. Infectious diseases
Published: October 01, 2024
Last Updated: 09/26/2026